 New York, New York--Newsfile Corp. - April 24, 2020 - Akers Biosciences NasdaqCM: AKER announced a licensing agreement with Premas Biotech to find an effective vaccine for COVID-19. Premas Biotech has over 125 employees and has delivered over 650 proteins and has completed over 240 separate projects 